A 24 settimane dal cambio di terapia, i pazienti passati a orforglipron hanno sostanzialmente mantenuto il peso perso (variazione media di 0,1 kg nel braccio ex-semaglutide e +2,6 kg in quello ex-tirzepatide), mentre chi passato a placebo ha recuperato oltre 9 kg in entrambi i bracci
Im just so grateful to be able to look at myself in the mirror and walk into a room without feeling self-conscious. The Downsides of GLP-1s for Moderate Weight Loss These are the main downsides to GLP-1 medications: Side effects : The most common are gastrointestinal symptomsnausea, diarrhea, and constipation
Lower blood pressure, reduced cholesterol levels, and improved blood sugar control are all heart-healthy outcomes of Semaglutide treatment, underscoring its value beyond mere weight loss
Or, they want me to be having another baby
GLP-1s prescribed specifically for weight loss, even if they were approved by the U.S